Penicillin Allergy Delabeling Can Decrease Antibiotic Resistance, Reduce Costs, and Optimize Patient Outcomes.
Journal
Federal practitioner : for the health care professionals of the VA, DoD, and PHS
ISSN: 1078-4497
Titre abrégé: Fed Pract
Pays: United States
ID NLM: 9500574
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
ppublish
Résumé
Antibiotics are one of the most frequently prescribed medications. Among all classes of antibiotics, penicillins are prescribed due to their clinical efficacy, cost-effectiveness, and general safety. Unfortunately, penicillins also are the most common drug allergy listed in patient medical records. Increasing evidence shows that > 90% of patients labeled with a penicillin allergy are not allergic to penicillins and associated β-lactams. The health care consequences of penicillin allergy in the setting of military medicine and readiness are important to consider. In the US, 8 to 10% of the population and up to 15% of hospitalized patients have a documented penicillin allergy, limiting the use of these effective antibiotics. When treating a patient with a penicillin allergy, many clinicians avoid prescribing all β-lactam antibiotics and stay away from cephalosporins due to the concern for potential cross-reactivity. The cost of treating those with a documented penicillin allergy is greater than the cost for those who can receive penicillin, as treatment with broad-spectrum antibiotics often results in longer hospitalizations with increased rates of adverse effects (AEs). Despite preventive programs such as vaccinations, hygiene measures, and prophylactic antibiotics, military personnel are at increased risk for infections due to the military's mobile nature and crowded living situations. Many patients report an allergy to penicillin, but only a small portion have a true immune-mediated allergy. Given the clinical, public health, and economic costs associated with a penicillin allergy label, evaluation and clearance of penicillin allergies improves clinical outcomes, decreases AEs from higher risk alternative broad-spectrum antibiotics, and prevents the spread of antibiotic resistance. In military personnel, penicillin delabeling improves readiness with optimal antibiotic options and avoidance of unnecessary risks, expediting return to full duty.
Sections du résumé
BACKGROUND
BACKGROUND
Antibiotics are one of the most frequently prescribed medications. Among all classes of antibiotics, penicillins are prescribed due to their clinical efficacy, cost-effectiveness, and general safety. Unfortunately, penicillins also are the most common drug allergy listed in patient medical records. Increasing evidence shows that > 90% of patients labeled with a penicillin allergy are not allergic to penicillins and associated β-lactams. The health care consequences of penicillin allergy in the setting of military medicine and readiness are important to consider.
OBSERVATIONS
METHODS
In the US, 8 to 10% of the population and up to 15% of hospitalized patients have a documented penicillin allergy, limiting the use of these effective antibiotics. When treating a patient with a penicillin allergy, many clinicians avoid prescribing all β-lactam antibiotics and stay away from cephalosporins due to the concern for potential cross-reactivity. The cost of treating those with a documented penicillin allergy is greater than the cost for those who can receive penicillin, as treatment with broad-spectrum antibiotics often results in longer hospitalizations with increased rates of adverse effects (AEs). Despite preventive programs such as vaccinations, hygiene measures, and prophylactic antibiotics, military personnel are at increased risk for infections due to the military's mobile nature and crowded living situations.
CONCLUSIONS
CONCLUSIONS
Many patients report an allergy to penicillin, but only a small portion have a true immune-mediated allergy. Given the clinical, public health, and economic costs associated with a penicillin allergy label, evaluation and clearance of penicillin allergies improves clinical outcomes, decreases AEs from higher risk alternative broad-spectrum antibiotics, and prevents the spread of antibiotic resistance. In military personnel, penicillin delabeling improves readiness with optimal antibiotic options and avoidance of unnecessary risks, expediting return to full duty.
Identifiants
pubmed: 33132684
doi: 10.12788/fp.0040
pii: fp-37-10-460
pmc: PMC7592897
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
460-465Informations de copyright
Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.
Déclaration de conflit d'intérêts
Author disclosures The author reports no actual or potential conflicts of interest with regard to this article.
Références
Clin Infect Dis. 2018 Jan 18;66(3):329-336
pubmed: 29361015
N Engl J Med. 2012 May 17;366(20):1881-90
pubmed: 22591294
N Engl J Med. 2005 Dec 8;353(23):2442-9
pubmed: 16322602
Clin Infect Dis. 2015 Feb 15;60(4):566-77
pubmed: 25409476
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):705-710
pubmed: 28366717
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):813-815
pubmed: 28341170
Immunol Allergy Clin North Am. 2017 Nov;37(4):643-662
pubmed: 28965632
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
BMJ. 2013 Mar 20;346:f1235
pubmed: 23525864
JAMA. 2019 Jan 15;321(2):188-199
pubmed: 30644987
Emerg Infect Dis. 1999 May-Jun;5(3):379-85
pubmed: 10341174
PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2448
pubmed: 24386494
Clin Infect Dis. 2015 Aug 1;61(3):361-7
pubmed: 25900170
Perm J. 2017;21:16-080
pubmed: 28333608
Mil Med. 2019 Mar 1;184(3-4):e163-e168
pubmed: 30137597
Allergy Asthma Proc. 2019 Jan 1;40(1):57-61
pubmed: 30582497
Emerg Infect Dis. 2006 Sep;12(9):1398-405
pubmed: 17073089
BMJ. 2018 Jun 27;361:k2400
pubmed: 29950489
JAMA. 2014 Oct 8;312(14):1438-46
pubmed: 25291579
Curr Allergy Asthma Rep. 2019 Mar 22;19(5):27
pubmed: 30903298
Ann Fam Med. 2014 Mar-Apr;12(2):121-7
pubmed: 24615307
J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):616-625.e7
pubmed: 28483315
Rev Infect Dis. 1988 Jan-Feb;10(1):125-30
pubmed: 3281218
J Allergy Clin Immunol. 2014 Mar;133(3):790-6
pubmed: 24188976
Clin Infect Dis. 2008 Sep 15;47(6):735-43
pubmed: 18694344
Clin Infect Dis. 2005 Nov 1;41(9):1254-60
pubmed: 16206099
Ann Allergy Asthma Immunol. 2006 Nov;97(5):681-7
pubmed: 17165279
PLoS One. 2016 Jul 20;11(7):e0159406
pubmed: 27438379
JAMA Intern Med. 2017 Sep 1;177(9):1308-1315
pubmed: 28604925
J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):252-7
pubmed: 24565481
BMC Infect Dis. 2016 May 23;16:224
pubmed: 27215201